Estrogen is known to regulate bone metabolism in both women and men, but substantial gaps remain in our knowledge of estrogen and estrogen receptor alpha (ERα) regulation of adult bone metabolism. Studies using global ERα-knockout mice were confounded by high circulating sex-steroid levels, and osteocyte/osteoblast-specific ERα deletion may be confounded by ERα effects on growth versus the adult skeleton. Thus, we developed mice expressing the tamoxifen-inducible CreERT2 in osteocytes using the 8-kilobase (kb) Dmp1 promoter (Dmp1CreERT2 ). These mice were crossed with ERαfl//fl mice to create ERαΔOcy mice, permitting inducible osteocyte-specific ERα deletion in adulthood. After intermittent tamoxifen treatment of adult 4-month-old mice for 1 month, female, but not male, ERαΔOcy mice exhibited reduced spine bone volume fraction (BV/TV (-20.1%, p = 0.004) accompanied by decreased trabecular bone formation rate (-18.9%, p = 0.0496) and serum P1NP levels (-38.9%, p = 0.014). Periosteal (+65.6%, p = 0.004) and endocortical (+64.1%, p = 0.003) expansion were higher in ERαΔOcy mice compared to control (Dmp1CreERT2 ) mice at the tibial diaphysis, reflecting the known effects of estrogen to inhibit periosteal apposition and promote endocortical formation. Increases in Sost (2.1-fold, p = 0.001) messenger RNA (mRNA) levels were observed in trabecular bone at the spine in ERαΔOcy mice, consistent with previous reports that estrogen deficiency is associated with increased circulating sclerostin as well as bone SOST mRNA levels in humans. Further, the biological consequences of increased Sost expression were reflected in significant overall downregulation in panels of osteoblast and Wnt target genes in osteocyte-enriched bones from ERαΔOcy mice. These findings thus establish that osteocytic ERα is critical for estrogen action in female, but not male, adult bone metabolism. Moreover, the reduction in bone formation accompanied by increased Sost, decreased osteoblast, and decreased Wnt target gene expression in ERαΔOcy mice provides a direct link in vivo between ERα and Wnt signaling. © 2022 American Society for Bone and Mineral Research (ASBMR).

Robert and Arlene Kogod Center on Aging and Division of Endocrinology Mayo Clinic College of Medicine Rochester MN USA

Robert and Arlene Kogod Center on Aging and Division of Hematology Mayo Clinic College of Medicine Rochester MN USA

University Hospital Hradec Kralove and the Faculty of Medicine in Hradec Kralove Hradec Kralove Czech Republic

Zobrazit více v PubMed

Khosla S, Melton LJ 3rd, Riggs BL. The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed? J Bone Miner Res. Mar 2011;26(3):441–51. Epub 2010/10/12. PubMed PMC

Khosla S, Monroe DG. Regulation of Bone Metabolism by Sex Steroids. Cold Spring Harb Perspect Med. Jan 2 2018;8(1). Epub 2017/07/16. PubMed PMC

Nicks KM, Fujita K, Fraser D, McGregor U, Drake MT, McGee-Lawrence ME, et al. Deletion of Estrogen Receptor Beta in Osteoprogenitor Cells Increases Trabecular but Not Cortical Bone Mass in Female Mice. J Bone Miner Res. Mar 2016;31(3):606–14. Epub 2015/09/30. PubMed PMC

Sims NA, Dupont S, Krust A, Clement-Lacroix P, Minet D, Resche-Rigon M, et al. Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males. Bone. Jan 2002;30(1):18–25. Epub 2002/01/17. PubMed

Almeida M, Iyer S, Martin-Millan M, Bartell SM, Han L, Ambrogini E, et al. Estrogen receptor-alpha signaling in osteoblast progenitors stimulates cortical bone accrual. J Clin Invest. Jan 2013;123(1):394–404. Epub 2012/12/12. PubMed PMC

Kondoh S, Inoue K, Igarashi K, Sugizaki H, Shirode-Fukuda Y, Inoue E, et al. Estrogen receptor alpha in osteocytes regulates trabecular bone formation in female mice. Bone. Mar 2014;60:68–77. Epub 2013/12/18. PubMed PMC

Melville KM, Kelly NH, Khan SA, Schimenti JC, Ross FP, Main RP, et al. Female mice lacking estrogen receptor-alpha in osteoblasts have compromised bone mass and strength. J Bone Miner Res. Feb 2014;29(2):370–9. Epub 2013/09/17. PubMed

Windahl SH, Borjesson AE, Farman HH, Engdahl C, Moverare-Skrtic S, Sjogren K, et al. Estrogen receptor-alpha in osteocytes is important for trabecular bone formation in male mice. Proc Natl Acad Sci U S A. Feb 5 2013;110(6):2294–9. Epub 2013/01/25. PubMed PMC

Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, Igarashi K, et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell. Sep 7 2007;130(5):811–23. Epub 2007/09/07. PubMed

Martin-Millan M, Almeida M, Ambrogini E, Han L, Zhao H, Weinstein RS, et al. The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol Endocrinol. Feb 2010;24(2):323–34. Epub 2010/01/08. PubMed PMC

Fujiwara Y, Piemontese M, Liu Y, Thostenson JD, Xiong J, O’Brien CA. RANKL (Receptor Activator of NFkappaB Ligand) Produced by Osteocytes Is Required for the Increase in B Cells and Bone Loss Caused by Estrogen Deficiency in Mice. J Biol Chem. Nov 25 2016;291(48):24838–50. Epub 2016/10/14. PubMed PMC

Kalajzic I, Braut A, Guo D, Jiang X, Kronenberg MS, Mina M, et al. Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgene. Bone. Jul 2004;35(1):74–82. Epub 2004/06/23. PubMed

Powell WF, Barry KJ, Tulum I, Kobayashi T, Harris SE, Bringhurst FR, et al. Targeted ablation of the PTH/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses. J Endocrinol. Apr 2011;209(1):21–32. Epub 2011/01/12. PubMed PMC

Bivi N, Condon KW, Allen MR, Farlow N, Passeri G, Brun LR, et al. Cell autonomous requirement of connexin 43 for osteocyte survival: consequences for endocortical resorption and periosteal bone formation. J Bone Miner Res. Feb 2012;27(2):374–89. Epub 2011/10/27. PubMed PMC

Feng Y, Manka D, Wagner KU, Khan SA. Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice. Proc Natl Acad Sci U S A. Sep 11 2007;104(37):14718–23. Epub 2007/09/06. PubMed PMC

Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci. Jan 2010;13(1):133–40. Epub 2009/12/22. PubMed PMC

Tasic B, Hippenmeyer S, Wang C, Gamboa M, Zong H, Chen-Tsai Y, et al. Site-specific integrase-mediated transgenesis in mice via pronuclear injection. Proc Natl Acad Sci U S A. May 10 2011;108(19):7902–7. Epub 2011/04/06. PubMed PMC

Zhang Z, Park JW, Ahn IS, Diamante G, Sivakumar N, Arneson D, et al. Estrogen receptor alpha in the brain mediates tamoxifen-induced changes in physiology in mice. Elife. Mar 1 2021;10. Epub 2021/03/02. PubMed PMC

Xie Z, McGrath C, Sankaran J, Styner M, Little-Letsinger S, Dudakovic A, et al. Low-Dose Tamoxifen Induces Significant Bone Formation in Mice. JBMR Plus. Mar 2021;5(3):e10450. Epub 2021/03/30. PubMed PMC

Kelly NH, Schimenti JC, Patrick Ross F, van der Meulen MC. A method for isolating high quality RNA from mouse cortical and cancellous bone. Bone. Nov 2014;68:1–5. Epub 2014/07/30. PubMed PMC

Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. Jun 18 2002;3(7):RESEARCH0034. Epub 2002/08/20. PubMed PMC

Farr JN, Fraser DG, Wang H, Jaehn K, Ogrodnik MB, Weivoda MM, et al. Identification of Senescent Cells in the Bone Microenvironment. J Bone Miner Res. Nov 2016;31(11):1920–9. Epub 2016/10/25. PubMed PMC

Tsai CA, Chen JJ. Multivariate analysis of variance test for gene set analysis. Bioinformatics. Apr 1 2009;25(7):897–903. Epub 2009/03/04. PubMed

Kalajzic I, Matthews BG, Torreggiani E, Harris MA, Divieti Pajevic P, Harris SE. In vitro and in vivo approaches to study osteocyte biology. Bone. Jun 2013;54(2):296–306. Epub 2012/10/18. PubMed PMC

Ahlborg HG, Johnell O, Turner CH, Rannevik G, Karlsson MK. Bone loss and bone size after menopause. N Engl J Med. Jul 24 2003;349(4):327–34. Epub 2003/07/25. PubMed

Turner RT, Wakley GK, Hannon KS. Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female rats. J Orthop Res. Jul 1990;8(4):612–7. Epub 1990/07/01. PubMed

Szulc P, Seeman E, Duboeuf F, Sornay-Rendu E, Delmas PD. Bone fragility: failure of periosteal apposition to compensate for increased endocortical resorption in postmenopausal women. J Bone Miner Res. Dec 2006;21(12):1856–63. Epub 2006/09/28. PubMed

Seeman E Bone quality: the material and structural basis of bone strength. J Bone Miner Metab. 2008;26(1):1–8. Epub 2007/12/21. PubMed

Syed FA, Fraser DG, Monroe DG, Khosla S. Distinct effects of loss of classical estrogen receptor signaling versus complete deletion of estrogen receptor alpha on bone. Bone. Aug 2011;49(2):208–16. Epub 2011/04/05. PubMed PMC

Li X, Ominsky MS, Niu QT, Sun N, Daugherty B, D’Agostin D, et al. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res. Jun 2008;23(6):860–9. Epub 2008/02/14. PubMed

Ponte F, Kim HN, Iyer S, Han L, Almeida M, Manolagas SC. Cxcl12 Deletion in Mesenchymal Cells Increases Bone Turnover and Attenuates the Loss of Cortical Bone Caused by Estrogen Deficiency in Mice. J Bone Miner Res. Aug 2020;35(8):1441–51. Epub 2020/03/11. PubMed PMC

Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest. Apr 2003;111(8):1221–30. Epub 2003/04/17. PubMed PMC

Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Spelsberg TC, Riggs BL. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology. Sep 1999;140(9):4367–70. Epub 1999/08/28. PubMed

Kedlaya R, Kang KS, Hong JM, Bettagere V, Lim KE, Horan D, et al. Adult-Onset Deletion of beta-Catenin in (10kb)Dmp1-Expressing Cells Prevents Intermittent PTH-Induced Bone Gain. Endocrinology. Aug 2016;157(8):3047–57. Epub 2016/06/03. PubMed PMC

Vooijs M, Jonkers J, Berns A. A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent. EMBO Rep. Apr 2001;2(4):292–7. Epub 2001/04/18. PubMed PMC

Raj A, van Oudenaarden A. Nature, nurture, or chance: stochastic gene expression and its consequences. Cell. Oct 17 2008;135(2):216–26. Epub 2008/10/30. PubMed PMC

Frame B The Earlier Gain and the Later Loss of Cortical Bone in Nutritional Perspective. Radiology. 1971;98(2):310-.

Niziolek PJ, Bullock W, Warman ML, Robling AG. Missense Mutations in LRP5 Associated with High Bone Mass Protect the Mouse Skeleton from Disuse- and Ovariectomy-Induced Osteopenia. PLoS One. 2015;10(11):e0140775. Epub 2015/11/12. PubMed PMC

Modder UI, Clowes JA, Hoey K, Peterson JM, McCready L, Oursler MJ, et al. Regulation of circulating sclerostin levels by sex steroids in women and in men. J Bone Miner Res. Jan 2011;26(1):27–34. Epub 2010/05/26. PubMed PMC

Modder UI, Roforth MM, Hoey K, McCready LK, Peterson JM, Monroe DG, et al. Effects of estrogen on osteoprogenitor cells and cytokines/bone-regulatory factors in postmenopausal women. Bone. Aug 2011;49(2):202–7. Epub 2011/05/10. PubMed PMC

Fujita K, Roforth MM, Demaray S, McGregor U, Kirmani S, McCready LK, et al. Effects of estrogen on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in postmenopausal women. J Clin Endocrinol Metab. Jan 2014;99(1):E81–8. Epub 2013/10/31. PubMed PMC

Chung YE, Lee SH, Lee SY, Kim SY, Kim HH, Mirza FS, et al. Long-term treatment with raloxifene, but not bisphosphonates, reduces circulating sclerostin levels in postmenopausal women. Osteoporos Int. Apr 2012;23(4):1235–43. Epub 2011/06/11. PubMed

Jastrzebski S, Kalinowski J, Stolina M, Mirza F, Torreggiani E, Kalajzic I, et al. Changes in bone sclerostin levels in mice after ovariectomy vary independently of changes in serum sclerostin levels. J Bone Miner Res. Mar 2013;28(3):618–26. Epub 2012/10/10. PubMed PMC

Most W, van der Wee-Pals L, Ederveen A, Papapoulos S, Lowik C. Ovariectomy and orchidectomy induce a transient increase in the osteoclastogenic potential of bone marrow cells in the mouse. Bone. Jan 1997;20(1):27–30. Epub 1997/01/01. PubMed

Weivoda MM, Ruan M, Hachfeld CM, Pederson L, Howe A, Davey RA, et al. Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways. J Bone Miner Res. Aug 2019;34(8):1546–8. Epub 2019/08/16. PubMed

Kobayashi Y, Thirukonda GJ, Nakamura Y, Koide M, Yamashita T, Uehara S, et al. Wnt16 regulates osteoclast differentiation in conjunction with Wnt5a. Biochem Biophys Res Commun. Aug 7 2015;463(4):1278–83. Epub 2015/06/21. PubMed

Chang M-K, Kramer I, Huber T, Kinzel B, Guth-Gundel S, Leupin O, et al. Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels. Proceedings of the National Academy of Sciences. 2014;111(48):E5187–E95. PubMed PMC

Zhou S, Turgeman G, Harris SE, Leitman DC, Komm BS, Bodine PV, et al. Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells. Mol Endocrinol. Jan 2003;17(1):56–66. Epub 2003/01/04. PubMed

Rickard DJ, Hofbauer LC, Bonde SK, Gori F, Spelsberg TC, Riggs BL. Bone morphogenetic protein-6 production in human osteoblastic cell lines. Selective regulation by estrogen. J Clin Invest. Jan 15 1998;101(2):413–22. Epub 1998/02/07. PubMed PMC

Matsumoto Y, Otsuka F, Takano-Narazaki M, Katsuyama T, Nakamura E, Tsukamoto N, et al. Estrogen facilitates osteoblast differentiation by upregulating bone morphogenetic protein-4 signaling. Steroids. May 2013;78(5):513–20. Epub 2013/03/19. PubMed

Fan JZ, Yang L, Meng GL, Lin YS, Wei BY, Fan J, et al. Estrogen improves the proliferation and differentiation of hBMSCs derived from postmenopausal osteoporosis through notch signaling pathway. Mol Cell Biochem. Jul 2014;392(1–2):85–93. Epub 2014/04/23. PubMed PMC

Jilka RL, Takahashi K, Munshi M, Williams DC, Roberson PK, Manolagas SC. Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. Evidence for autonomy from factors released during bone resorption. J Clin Invest. May 1 1998;101(9):1942–50. Epub 1998/06/13. PubMed PMC

Plotkin LI, Aguirre JI, Kousteni S, Manolagas SC, Bellido T. Bisphosphonates and estrogens inhibit osteocyte apoptosis via distinct molecular mechanisms downstream of extracellular signal-regulated kinase activation. J Biol Chem. Feb 25 2005;280(8):7317–25. Epub 2004/12/14. PubMed

Farr JN, Rowsey JL, Eckhardt BA, Thicke BS, Fraser DG, Tchkonia T, et al. Independent Roles of Estrogen Deficiency and Cellular Senescence in the Pathogenesis of Osteoporosis: Evidence in Young Adult Mice and Older Humans. J Bone Miner Res. Aug 2019;34(8):1407–18. Epub 2019/03/27. PubMed PMC

Khosla S New Insights Into Androgen and Estrogen Receptor Regulation of the Male Skeleton. J Bone Miner Res. Jul 2015;30(7):1134–7. Epub 2015/04/11. PubMed PMC

Jilka RL. The relevance of mouse models for investigating age-related bone loss in humans. J Gerontol A Biol Sci Med Sci. Oct 2013;68(10):1209–17. Epub 2013/05/22. PubMed PMC

Jardí F, Laurent MR, Dubois V, Khalil R, Deboel L, Schollaert D, et al. A shortened tamoxifen induction scheme to induce CreER recombinase without side effects on the male mouse skeleton. Mol Cell Endocrinol. Sep 5 2017;452:57–63. Epub 2017/05/16. PubMed

Ward WE, Piekarz AV, Fonseca D. Bone mass, bone strength, and their relationship in developing CD-1 mice. Can J Physiol Pharmacol. Feb 2007;85(2):274–9. Epub 2007/05/10. PubMed

Interindividual differences contribute to variation in microbiota composition more than hormonal status: A prospective study